Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08970 | 31921154 | Front Immunol | Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. | 2019 | Details |
| A08973 | 31919793 | Pharmacoeconomics | Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements. | 2020 | Details |
| A08975 | 31919231 | Gut | S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. | 2020 | Details |
| A08976 | 31918923 | Mol Metab | Deletion of iRhom2 protects against diet-induced obesity by increasing thermogenesis. | 2019 | Details |
| A08983 | 31915635 | Prev Nutr Food Sci | Beneficial Effects of Low-Calorie-Carbohydrate/High-Agar Diet on Cardiometabolic Disorders Associated with Non-Alcoholic Fatty Liver Disease in Obese Rats. | 2019 | Details |
| A08984 | 31915606 | J Clin Transl Hepatol | Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A08996 | 31910634 | Arch Iran Med | Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review. | 2020 | Details |
| A09002 | 31908001 | FASEB J | An energy restriction-based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor-promoting genes. | 2019 | Details |
| A09008 | 31906711 | Physiol Int | A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver disease. | 2019 | Details |
| A09009 | 31905727 | Nutrients | Intestinal Fructose and Glucose Metabolism in Health and Disease. | 2019 | Details |
| A09010 | 31905444 | Ann Pediatr Endocrinol Metab | Application of body composition zones in boys with nonalcoholic fatty liver disease. | 2019 | Details |
| A09011 | 31905026 | Am J Physiol Gastrointest Liver Physiol | Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis. | 2020 | Details |
| A09025 | 31900291 | Gut | Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease. | 2020 | Details |
| A09026 | 31899984 | Expert Opin Investig Drugs | Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis. | 2020 | Details |
| A09031 | 31898413 | Am J Transplant | OPTN/SRTR 2018 Annual Data Report: Liver. | 2020 | Details |
| A09037 | 31894585 | J Food Biochem | Royal jelly attenuates nonalcoholic fatty liver disease by inhibiting oxidative stress and regulating the expression of circadian genes in ovariectomized rats. | 2020 | Details |
| A09040 | 31893310 | Cell Mol Life Sci | Integrative genomics reveal a role for MCPIP1 in adipogenesis and adipocyte metabolism. | 2019 | Details |
| A09047 | 31889754 | J Clin Exp Hepatol | Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09049 | 31889539 | Transplant Proc | Minimally Invasive Sleeve Gastrectomy as a Surgical Treatment for Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. | 2019 | Details |
| A09054 | 31888190 | Nutrients | Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl/6 Models. | 2019 | Details |
| A09057 | 34350368 | Cardiol Plus | Bile Acid and Cholesterol Metabolism in Atherosclerotic Cardiovascular Disease and Therapy. | 2020 | Details |
| A09060 | 33740854 | Vnitr Lek | The role of metabolic syndrome in the induction of chronic pancreatitis after a first attack of acute pancreatitis - multicenter trial. | 2020 | Details |
| A09061 | 31887811 | Gut Liver | Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index. | 2020 | Details |
| A09067 | 31885746 | Dis Markers | Circulating Hsp90 Isoform Levels in Overweight and Obese Children and the Relation to Nonalcoholic Fatty Liver Disease: Results from a Cross-Sectional Study. | 2019 | Details |
| A09074 | 31883514 | BMC Gastroenterol | Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH. | 2019 | Details |
| A09076 | 31883408 | Liver Int | Farnesoid X receptor activation induces the degradation of hepatotoxic 1-deoxysphingolipids in non-alcoholic fatty liver disease. | 2020 | Details |
| A09080 | 31882566 | Diabetes | The Novel Adipokine Gremlin 1 Antagonizes Insulin Action and Is Increased in Type 2 Diabetes and NAFLD/NASH. | 2019 | Details |
| A09081 | 31882442 | Pharmacol Rev | Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease. | 2020 | Details |
| A09090 | 31880680 | J Pediatr Gastroenterol Nutr | Early Obesity: Risk Factor for Fatty Liver Disease. | 2020 | Details |
| A09091 | 31880257 | Curr Protein Pept Sci | Role of BCL-2 Family Proteins in Apoptosis and its Regulation by Nutrients. | 2020 | Details |
| A09092 | 31880161 | Rev Esp Enferm Dig | Risk factors differentially associated with non-alcoholic fatty liver disease in males and females with metabolic syndrome. | 2020 | Details |
| A09097 | 31877680 | Int J Mol Sci | Mechanistic Insight of Na/K-ATPase Signaling and HO-1 into Models of Obesity and Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09102 | 31875010 | Sci Rep | The assessment of liver fibrosis in children with obesity on two methods: transient and two dimensional shear wave elastography. | 2019 | Details |
| A09108 | 31870938 | Peptides | Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction. | 2019 | Details |
| A09113 | 31870087 | Korean J Pediatr | Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity. | 2019 | Details |
| A09119 | 31867441 | Hepatoma Res | Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma. | 2019 | Details |
| A09120 | 31867105 | Cancer Metab | SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia. | 2019 | Details |
| A09127 | 31865317 | Dig Dis | Nonalcoholic Fatty Pancreas Disease: Clinical Consequences. | 2019 | Details |
| A09128 | 31865143 | Biomed Pharmacother | Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model. | 2019 | Details |
| A09131 | 31863408 | Obes Surg | Outcomes of Bariatric Surgery in Chronic Liver Disease: a National Inpatient Sample Analysis. | 2020 | Details |
| A09132 | 31862949 | Sci Rep | Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitis. | 2019 | Details |
| A09133 | 31862937 | Sci Rep | Urinary Levels of Titin-N Fragment, a Skeletal Muscle Damage Marker, are Increased in Subjects with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09134 | 31862486 | J Hepatol | Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A09138 | 31861591 | J Clin Med | Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy. | 2019 | Details |
| A09139 | 31861497 | Nutrients | Protective Effect of α-Linolenic Acid on Non-Alcoholic Hepatic Steatosis and Interleukin-6 and -10 in Wistar Rats. | 2019 | Details |
| A09147 | 31858390 | Endocrine | Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity. | 2019 | Details |
| A09148 | 31858105 | J Nutr | Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet. | 2020 | Details |
| A09153 | 31856189 | PLoS One | Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy. | 2019 | Details |
| A09154 | 31854001 | Alcohol Clin Exp Res | Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies. | 2020 | Details |
| A09155 | 31853866 | Obes Surg | Bariatric Surgery in Cirrhotic Patients: Is It Safe? | 2020 | Details |
| A09158 | 31852647 | Nan Fang Yi Ke Da Xue Xue Bao | [Predictive value of body mass index combined with waist circumference for new-onset nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus]. | 2019 | Details |
| A09159 | 31852635 | Lancet Gastroenterol Hepatol | Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. | 2019 | Details |
| A09171 | 31850288 | Front Pediatr | Metabolic Syndrome Is Associated With Advanced Liver Fibrosis Among Pediatric Patients With Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A09178 | 31847157 | Nutrients | Sarcopoterium spinosum Inhibited the Development of Non-Alcoholic Steatosis and Steatohepatitis in Mice. | 2019 | Details |
| A09180 | 31846507 | Swiss Med Wkly | Nonalcoholic fatty liver disease burden - Switzerland 2018-2030. | 2019 | Details |
| A09181 | 31846425 | J Pediatr Endocrinol Metab | Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesity. | 2020 | Details |
| A09184 | 31845054 | J Gastroenterol | Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. | 2019 | Details |
| A09186 | 31843573 | J Ethnopharmacol | San-Huang-Tang protects obesity/diabetes induced NAFLD by upregulating PGC-1α/PEPCK signaling in obese and galr1 knockout mice models. | 2019 | Details |
| A09189 | 31842467 | Int J Mol Sci | Resveratrol Treatment Enhances the Cellular Response to Leptin by Increasing OBRb Content in Palmitate-Induced Steatotic HepG2 Cells. | 2019 | Details |
| A09193 | 31840865 | Nutr Clin Pract | Evolution of NAFLD and Its Management. | 2019 | Details |
| A09198 | 31838461 | Nutrition | Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features. | 2019 | Details |
| A09199 | 31838198 | Prostaglandins Other Lipid Mediat | Cd36 gene expression in adipose and hepatic tissue mediates the lipids accumulation in liver of obese rats with sucrose-induced hepatic steatosis. | 2019 | Details |
| A09206 | 31836013 | BMC Complement Altern Med | Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice. | 2019 | Details |
| A09207 | 31835505 | Nutrients | Weight Gain and De Novo Metabolic Disorders after Liver Transplantation. | 2019 | Details |
| A09214 | 31834057 | Eur J Gastroenterol Hepatol | Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter. | 2020 | Details |
| A09217 | 31832925 | Biol Trace Elem Res | Effect of Zn Supplementation on Trace Element Status in Rats with Diet-Induced Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A09221 | 31832499 | GE Port J Gastroenterol | Fatty Liver Caused by Glycogen Storage Disease Type IX: A Small Series of Cases in Children. | 2019 | Details |
| A09222 | 31832001 | World J Gastroenterol | LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway. | 2019 | Details |
| A09223 | 31831718 | Aging (Albany NY) | Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes. | 2019 | Details |
| A09228 | 31828503 | Langenbecks Arch Surg | A retrospective case control study identifies peripheral blood mononuclear cell albumin RNA expression as a biomarker for non-alcoholic fatty liver disease. | 2019 | Details |
| A09230 | 31827150 | Sci Rep | Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population. | 2019 | Details |
| A09232 | 31826069 | J Gastrointestin Liver Dis | PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes. | 2019 | Details |
| A09235 | 31825539 | Aliment Pharmacol Ther | Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis. | 2019 | Details |
| A09236 | 31824620 | Middle East J Dig Dis | Burden of Liver Diseases: A Review from Iran. | 2019 | Details |
| A09239 | 31822739 | Sci Rep | Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. | 2019 | Details |
| A09247 | 31819375 | Drug Des Devel Ther | Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways. | 2019 | Details |
| A09249 | 31817648 | Nutrients | High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths. | 2019 | Details |
| A09250 | 31817623 | J Clin Med | Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study. | 2019 | Details |
| A09257 | 31815784 | Curr Opin Endocrinol Diabetes Obes | Gastrointestinal peptides and nonalcoholic fatty liver disease. | 2020 | Details |
| A09259 | 31814783 | Hepat Med | A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A09264 | 31812658 | Clin Gastroenterol Hepatol | Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men. | 2019 | Details |
| A09269 | 31810499 | Syst Rev | The impact of environmental cadmium exposure on type 2 diabetes risk: a protocol for an overview of systematic reviews. | 2019 | Details |
| A09270 | 31810110 | Pediatr Obes | Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German-speaking countries. Analysis of the APV initiative. | 2019 | Details |
| A09275 | 31809000 | J Cell Mol Med | Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes. | 2019 | Details |
| A09277 | 31808444 | Cureus | Lifestyle Intervention Framework for Obese Patients with Non-alcoholic Fatty Liver Disease - a Tool for Health Professionals in Resource Constraint Settings. | 2019 | Details |
| A09280 | 31808097 | Environ Sci Pollut Res Int | Could phthalates exposure contribute to the development of metabolic syndrome and liver disease in humans? | 2019 | Details |
| A09285 | 31805752 | Molecules | Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge from Cellular and Animal Models. | 2019 | Details |
| A09286 | 31805573 | Horm Res Paediatr | Increased Prevalence of Severe Obesity and Related Comorbidities among Patients Referred to a Pediatric Obesity Clinic during the Last Decade. | 2019 | Details |
| A09287 | 31805072 | PLoS One | Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A09288 | 31805015 | J Clin Invest | Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. | 2020 | Details |
| A09293 | 31803485 | BMJ Open Diabetes Res Care | Determinants of longitudinal change in insulin clearance: the Prospective Metabolism and Islet Cell Evaluation cohort. | 2019 | Details |
| A09295 | 31802390 | Hepatol Int | New drugs for NAFLD: lessons from basic models to the clinic. | 2019 | Details |
| A09296 | 31801616 | J Transl Med | Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study. | 2019 | Details |
| A09300 | 31800592 | PLoS One | Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis. | 2019 | Details |
| A09301 | 31799714 | Phytother Res | The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials. | 2019 | Details |
| A09306 | 31797544 | Mol Nutr Food Res | Vitamin D Deficiency Induces Insulin Resistance and Re-Supplementation Attenuates Hepatic Glucose Output via the PI3K-AKT-FOXO1 Mediated Pathway. | 2020 | Details |
| A09312 | 31795496 | Cells | Pin1 Plays Essential Roles in NASH Development by Modulating Multiple Target Proteins. | 2019 | Details |
| A09316 | 31793324 | Nutr Hosp | Immunonutritional contribution of gut microbiota to fatty liver disease. | 2020 | Details |
| A09322 | 31790897 | Phytomedicine | Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway. | 2019 | Details |
| A09326 | 31789950 | Eur J Gastroenterol Hepatol | Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes. | 2020 | Details |